Sign in
4

Changes in Ownership

Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-23-030092

CEO & Chief Scientific Officer acquired 115,684 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Zhang Jack Y. CEO & Chief Scientific Officer 2023-03-06 Grant or award +81,383 2,185,526 D: show line 1 in the form
Zhang Jack Y. CEO & Chief Scientific Officer 2023-03-06 Grant or award +34,301 1,532,820 I: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Zhang Jack Y. CEO & Chief Scientific Officer 2023-03-06 Grant or award · Employee Stock Option (right to buy) +171,488 171,488 D: show line 3 in the form
Zhang Jack Y. CEO & Chief Scientific Officer 2023-03-06 Grant or award · Employee Stock Option (right to buy) +72,278 72,278 I: show line 4 in the form
Loading xslF345X03/tm238753-1_4seq1.xml…